In February 2017, the FDA approved Immunexpress's SeptiCyte, a molecular test with an indication for diagnosing sepsis on the first day of ICU treatment.
Sepsis blood test with high accuracy may be…
In February 2017, the FDA approved Immunexpress's SeptiCyte, a molecular test with an indication for diagnosing sepsis on the first day of ICU treatment.